iCHOR Vascular Inc

One size fits all solution for peripheral clot removal (DVT & PAD) without the need for drugs or surgical intervention.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Minneapolis, MN, USA
  • Currency USD
  • Founded November 2014
  • Employees 3
  • Incorporation Type C-corp
  • Website ichorvascular.com

Company Summary

ICHOR Vascular has 510(k) market clearance for a 7F Percutaneous Arterial Reperfusion System (clot removal)! The 14F System is optimized for venous thrombosis and was recently 510(k) cleared on Sept 5th, 2023. ICHOR aims to be the future in treating a wide range of vascular occlusions by offering a singular product with broad utility.

Advisors

  • Mike Cohn, MD
    Unconfirmed
    Troy Long Md
    Unconfirmed
    George Adams, Md (UNC)
    Unconfirmed
  • Ken Ouriel, MD
    Unconfirmed

Previous Investors

  • Cleveland Clinic (GCIC)
    Unconfirmed
    OSF (Peoria, IL)
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free